Form 4: Guardant Health Executive Darya Chudova Reports Stock Transactions

Darya Chudova, Chief Technology Officer of Guardant Health, reports the vesting of restricted stock units and related tax withholding.

Summary

• On June 1, 2024, Darya Chudova, Chief Technology Officer of Guardant Health, Inc., reported transactions involving common stock.
• 315 shares were acquired upon the vesting of restricted stock units at a price of $0.
• 113 shares were disposed of to cover tax withholding obligations at a price of $27.1 per share.
• Following these transactions, Chudova directly owns 43,202 shares of common stock and 1,579 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.

Positives

• The vesting of restricted stock units indicates a continued alignment of the executive's interests with the company's performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors to gauge executive sentiment and potential future stock performance.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units as a way to align executive interests with shareholder value.
• Tax withholding practices related to equity compensation are standard across publicly traded companies.
• The vesting schedule of the restricted stock units (quarterly installments) is a common practice.

Stakeholder Impact

• Shareholders are informed about executive stock transactions, providing transparency into insider activity.

Key Dates